title: CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway.
abstract: The possibility that the sphingomyelin (SM)-ceramide pathway is activated by CD40, a transmembrane glycoprotein belonging to the tumor necrosis factor receptor superfamily and that plays a critical role in the regulation of immune responses has been investigated. We demonstrate that incubation of Epstein-Barr virus-transformed lymphoid cells with an anti-CD40 antibody acting as an agonist results in the stimulation of a neutral sphingomyelinase, hydrolysis of cellular SM, and concomitant ceramide generation. In addition, SM degradation was observed in acid sphingomyelinase-deficient cells, as well as after ligation by soluble CD40 ligand. The anti-CD40 antibody, as well as the soluble CD40 ligand induced a decrease in thymidine incorporation and morphological features of apoptosis, which were mimicked by cell-permeant or bacterial sphingomyelinase-produced ceramides. Stable expression of a dominant-negative form of the FAN protein (factor associated with neutral sphingomyelinase activation), which has been reported to mediate tumor necrosis factor-induced activation of neutral sphingomyelinase, significantly inhibited CD40 ligand-induced sphingomyelinase stimulation and apoptosis of transformed human fibroblasts. Transformed fibroblasts from FAN knockout mice were also protected from CD40-mediated cell death. Finally, anti-CD40 antibodies were able to co-immunoprecipitate FAN in control fibroblasts but not in cells expressing the dominant-negative form of FAN, indicating interaction between CD40 and FAN. Altogether, these results strongly suggest that CD40 ligation can activate via FAN a neutral sphingomyelinase-mediated ceramide pathway that is involved in the cell growth inhibitory effects of CD40.
authors.affiliation: INSERM U466, Laboratoire de Biochimie, Institut Louis Bugnard, Bâtiment L3, Centre Hospitalier Universitaire Rangueil, 1 Avenue Jean Poulhès, F-31403 Toulouse Cedex 4, France.
authors.forename: B
authors.initials: B
authors.lastname: Ségui
authors.forename: N
authors.initials: N
authors.lastname: Andrieu-Abadie
authors.forename: S
authors.initials: S
authors.lastname: Adam-Klages
authors.forename: O
authors.initials: O
authors.lastname: Meilhac
authors.forename: D
authors.initials: D
authors.lastname: Kreder
authors.forename: V
authors.initials: V
authors.lastname: Garcia
authors.forename: A P
authors.initials: AP
authors.lastname: Bruno
authors.forename: J P
authors.initials: JP
authors.lastname: Jaffrézou
authors.forename: R
authors.initials: R
authors.lastname: Salvayre
authors.forename: M
authors.initials: M
authors.lastname: Krönke
authors.forename: T
authors.initials: T
authors.lastname: Levade
mesh_terms: D000818:Animals; D017209:Apoptosis; D019013:CD40 Antigens / Q000502:physiology*; D002455:Cell Division; D002460:Cell Line; D002472:Cell Transformation, Viral; D002518:Ceramides / Q000502:physiology*; D004854:Herpesvirus 4, Human; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D051379:Mice; D011506:Proteins / Q000502:physiology*; D015398:Signal Transduction; D013109:Sphingomyelins / Q000502:physiology*
chemical_list: D019013:CD40 Antigens; D002518:Ceramides; D047908:Intracellular Signaling Peptides and Proteins; C102036:NSMAF protein, human; C491112:Nsmaf protein, mouse; D011506:Proteins; D013109:Sphingomyelins